Essential thrombocythaemia (ET)
Essential thrombocythaemia (ET) is a slow-growing form of blood cancer. In ET, your body produces too many platelets (a type of blood cell).
Essential thrombocythaemia (ET) at a glance
ET is a type of blood cancer. It belongs to a group of conditions that affect the blood called myeloproliferative neoplasms (MPN).
ET is a very slow-developing blood cancer and for most people, doesn’t affect how long they live for.
Order our free booklet 'Your blood cancer diagnosis - what happens now?'. It tells you the key things to know about blood cancer, including tips from other people who've been diagnosed.
You may not experience any symptoms at all if you have ET, even once you’re diagnosed. Many people with ET are diagnosed after a routine blood test.
The most common tests to diagnose ET are a full blood count, tests for genetic faults and a bone marrow biopsy.
Your treatment will depend on how likely you are to develop complications, and also factors such as your age, your medical history and platelet count. This will help your healthcare team plan the best treatment option for you.
ET usually develops very slowly. With proper monitoring and treatment, ET does not affect most people’s quality of life or life expectancy.
Clinical trials are how we find new treatments and improve current ones. We can help you find out about clinical trials for ET. Even if you just want to know a bit more about ET research, try our Clinical Trials Support Service.
Our previous research has focused on improving treatments for blood cancers. Read about our research impact.
Living well
Practical tips and real stories to help you with everyday life
